1. Home
  2. TECH vs BFAM Comparison

TECH vs BFAM Comparison

Compare TECH & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • BFAM
  • Stock Information
  • Founded
  • TECH 1976
  • BFAM 1986
  • Country
  • TECH United States
  • BFAM United States
  • Employees
  • TECH N/A
  • BFAM N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • BFAM Other Consumer Services
  • Sector
  • TECH Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • TECH Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • TECH 7.8B
  • BFAM 7.1B
  • IPO Year
  • TECH 1989
  • BFAM 1997
  • Fundamental
  • Price
  • TECH $48.40
  • BFAM $129.36
  • Analyst Decision
  • TECH Buy
  • BFAM Buy
  • Analyst Count
  • TECH 11
  • BFAM 8
  • Target Price
  • TECH $72.00
  • BFAM $139.13
  • AVG Volume (30 Days)
  • TECH 2.9M
  • BFAM 560.0K
  • Earning Date
  • TECH 05-07-2025
  • BFAM 05-05-2025
  • Dividend Yield
  • TECH 0.66%
  • BFAM N/A
  • EPS Growth
  • TECH N/A
  • BFAM 93.82
  • EPS
  • TECH 0.83
  • BFAM 2.77
  • Revenue
  • TECH $1,208,770,000.00
  • BFAM $2,728,831,000.00
  • Revenue This Year
  • TECH $7.16
  • BFAM $9.64
  • Revenue Next Year
  • TECH $6.36
  • BFAM $7.16
  • P/E Ratio
  • TECH $58.31
  • BFAM $46.66
  • Revenue Growth
  • TECH 4.72
  • BFAM 9.71
  • 52 Week Low
  • TECH $46.01
  • BFAM $100.59
  • 52 Week High
  • TECH $83.62
  • BFAM $141.90
  • Technical
  • Relative Strength Index (RSI)
  • TECH 45.79
  • BFAM 57.47
  • Support Level
  • TECH $47.25
  • BFAM $127.28
  • Resistance Level
  • TECH $49.92
  • BFAM $132.99
  • Average True Range (ATR)
  • TECH 1.87
  • BFAM 3.30
  • MACD
  • TECH 0.16
  • BFAM 0.52
  • Stochastic Oscillator
  • TECH 28.14
  • BFAM 64.47

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

Share on Social Networks: